周一最大的股票变动者：RAPP、HORE、IDYA、NFE等

U.S. stock futures edged up on Monday as investors looked ahead to two important inflation reports this week, that will shape expectations for the Federal Reserve's next move.

Here are some of Monday's biggest stock movers:

Biggest stock gainers

Rapport Therapeutics (NASDAQ:RAPP) +25.4% - Shares surged following the announcement that it would release new data on its drug, RAP-219. The drug is a candidate for treating drug-resistant focal onset seizures. The company plans to release a primary analysis of the Phase 2a data, which will show how many patients achieved at least a 30% reduction in long episodes, a key indicator of clinical seizures. The report will also include the median percentage change in the frequency of these episodes.

AppLovin Corporation (NASDAQ:APP) +7.5% and Robinhood Markets (NASDAQ:HOOD) +7.3% - Stocks surged on Monday, extending their rally from Friday after it was announced they would be added to the S&P 500 Index. These companies will replace MarketAxess Holdings (NASDAQ: MKTX) and Caesars Entertainment (NASDAQ: CZR). 

Hour Loop (NASDAQ:HOUR) +11.5% - Stocks surged in premarket trading on Monday, extending their rally from Friday as the stock had experienced a significant price increase, making it the top gainer on the Nasdaq. The surge was not supported by any press releases or positive company news. The price increase was attributed to a high-volume, "meme-like" trading event, which is not a typical pattern for the stock.

Ideaya Biosciences (NASDAQ:IDYA) +15.2% – Shares jumped after IDYA and its partner, Hengrui Pharma, presented promising initial data from a Phase 1 clinical trial of their drug, IDE849, a new cancer treatment. The data, shared at the World Conference on Lung Cancer, showed strong efficacy, particularly in second-line small cell lung cancer patients. The drug achieved a 77.1% overall response rate in these patients and a 60.0% confirmed overall response rate.

Biggest stock losers

New Fortress Energy (NASDAQ:NFE) -12.7% – Shares tumbled after it reported a significant net loss of $556.8 million for the second quarter, compared to a loss of $86.9 million in the same period last year. The loss was due to lower contributions from asset sales, which also caused adjusted EBITDA to swing to a $3.7 million loss from a $120.2 million profit. Revenue also fell to $301.7 million from $428 million. The company expects its core earnings to improve as new projects in Brazil and Nicaragua, and expansions in Puerto Rico, become operational. It also noted that its PortoCem power plant in Brazil is over 70% complete

More on related stocks:

Robinhood and AppLovin rally after S&P 500 inclusion; Strategy falls after missing out

Hour Loop skyrockets in a meme-like, high-volume move

New Fortress Energy reports larger losses in Q2

Rapport Therapeutics soars 23% on release of phase 2 data for seizure asset